Pegasus Pharmaceuticals Inc. Release: Clinical Studies Completed for HeartVue's 6S Heart Screening System

PALM BEACH GARDENS, FL--(Marketwire - August 18, 2008) - Pegasus/Heartview LLC (PINKSHEETS: PGUZ) today announced that they have now completed the required clinical studies, which are an integral part of the process required for the marketing of the Company's breakthrough HeartVue 6S Heart Screening System in North America.

Back to news